Cosupplementation with Coenzyme Q Prevents the Prpoxidant Effect of α-Tocopherol and Increases the Resistance of LDL to Transition Metal-Dependent Oxidation Initiation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 5, 1996, Pages 687-696

  Thomas, Shane R ^a   Neužil, Jiří ^a   Stocker, Roland ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Atherosclerosis; Lipid hydroperoxides; Macrophage; Ubiquinone; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; LOW DENSITY LIPOPROTEIN; UBIQUINONE;

ADULT; ARTICLE; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPID ANALYSIS; LIPID OXIDATION; LIPOPROTEIN METABOLISM; MONOCYTE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

CELL LINE; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; METALS; MONOCYTES; OXIDATION-REDUCTION; REFERENCE VALUES; UBIQUINONE; VITAMIN E; VITAMIN E DEFICIENCY;

EID: 0029878284     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.5.687     Document Type: Article

References (54)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
2. Steinbrecher UP, Zhang H, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radie Biol Med. 1990;9: 155-168.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
4. Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897-930.
5. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA. 1984;81: 3883-3887.
6. Cathcart MK, Morel DW, Chisolm GM III. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J Leukoc Biol. 1985;38:341-350.
7. Lamb DJ, Wilkins GM, Leake DS. The oxidative modification of low density lipoprotein by human lymphocytes. Atherosclerosis. 1992;92:187-192.
8. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein in vitro by free radical oxidation. J Clin Invest. 1984;74:1890-1894.
9. Frei B, Gaziano JM. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J Lipid Res. 1993;34:2135-2145.
10. Kontush A, Hübner C, Finckh B, Kohlschütter A, Beisiegel U. Low density lipoprotein oxidizability by copper correlates to its initial ubiquinol-10 and polyunsaturated fatty acid content. FEBS Lett. 1994;341:69-73.
11. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci USA. 1991;88:1646-1650.
12. Burton GW, Ingold KU. Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and function. Acc Chem Res. 1986;19:194-201.
13. Esterbauer H, Jürgens G, Quehenberger O, Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res. 1987; 28:495-509.
14. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
15. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
16. The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
17. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA. 1987;84:5928-5931.
18. Björkhem I, Henriksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L, Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arteriosder Thromb. 1991; 11:15-22.
19. Mao SJ, Yates MT, Parker RA, Chi EM, Jackson RL. Attenuation of atherosclerosis in a modified strain of hypercholesteroiemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol. Arteriosder Thromb. 1991;11: 1266-1275.
20. Sparrow CP, Doebber TW, Olszewski J, Wu MS, Ventre J, Stevens KA, Chao YS. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine. J Clin Invest. 1992;89:1885-1891.
21. Fruebis J, Steinberg D, Dresel HA, Carew TA. A comparison of the antiatherogenic effects of probucol and a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits. J Clin Invest. 1994;94:392-398.
22. Mao SJ, Yates MT, Rechtin AE, Jackson RL, Van-Sickle WA. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits. J Med Chem. 1991;34:298-302.
23. Parthasarathy S. Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein: use of a new water-soluble probucol derivative. J Clin Invest. 1992;89:1618-1621.
24. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res. 1991;32:1325-1332.
25. Reaven PD, Witztum JL. Comparison of supplementation of RRR-α-tocopherol and racemic a-tocopherol in humans: effects on lipid levels and lipoprotein susceptibility to oxidation. Arterioscler Thromb. 1993;13:601-608.
26. Jialal I, Fuller CJ, Huet BA. The effect of α-tocopherol supplementation on LDL oxidation: a dose-response study. Arterioscler Thromb Vase Biol. 1995;15:190-198.
27. Jessup W, Rankin SM, De Whalley CV, Hoult JRS, Scott J, Leake DS. α-Tocopherol consumption during low-density lipoprotein oxidation. Biochem J. 1990;265:399-405.
28. Williams RJ, Motteram JM, Sharp CH, Gallagher PJ. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis. 1992;94:153-159.
29. Daugherty A, Zweifel BS, Sobel BE, Schonfeld G. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis. 1988;8: 768-777.
30. Steinbrecher UP, Lougheed M. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. Arterioscler Thromb. 1992;12:608-625.
31. Suarna C, Dean RT, May J, Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler Thromb Vase Biol. 1995;15: 1616-1624.
32. Mohr D, Bowry VW, Stocker R. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low density lipoprotein to the initiation of lipid peroxidation. Biochim Biophys Acta. 1992;1126:247-254.
33. Bowry VW, Stocker R. Tocopherol-mediated peroxidation: the pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc. 1993;115: 6029-6040.
34. Neužil J, Stocker R. Free and albumin-bound bilirubin is an efficient co-antioxidant for α-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem. 1994;269: 16712-16719.
35. Bowry VW, Ingold KU, Stocker R. Vitamin E in human low-density lipoprotein: when and how this antioxidant becomes a pro-oxidant. Biochem J. 1992;288:341-344.
36. Ingold KU, Bowry VW, Stocker R, Walling C. Autoxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: the unrecognized consequences of lipid particle size as exemplified by the oxidation of human low density lipoprotein. Proc Natl Acad Sci USA. 1993;90:45-49.
37. Christen S, Thomas SR, Garner B, Stocker R. Inhibition by interferon-γ of human mononuclear cell-mediated low density lipoprotein oxidation: participation of tryptophan metabolism along the kynurenine pathway. J Clin Invest. 1994;93:2149-2158.
38. Sattler W, Mohr D, Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence. Methods Enzymol. 1994;233:469-489.
39. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr. 1991;53:314S-321S.
40. Traber MG, Sokol RJ, Burton GW, Ingold KU, Papas AM, Huffaker JE, Kayden HJ. Impaired ability of patients with familial isolated vitamin E deficiency to incorporate α-tocopherol. J Clin Invest. 1990;85:397-407.
41. Traber MG, Sokol RJ, Kohlschütter A, Yokota T, Muller DP, Dufour R, Kayden HJ. Impaired discrimination between stereoisomers of alpha-tocopherol in patients with familial isolated vitamin E deficiency. J Lipid Res. 1993;34:201-210.
42. Yamamoto Y, Brodsky MH, Baker JC, Ames BN. Detection and characterization of lipid hydroperoxides at picomole levels by high-performance liquid chromatography. Anal Biochem. 1987;160:7-13.
43. Burton GW, Ingold KU. Autoxidation of biological molecules, 1: the antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J Am Chem Soc. 1981;103:6472-6477.
44. Sparrow CP, Olszewski J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J Lipid Res. 1993;34:1219-1228.
45. Kayden HJ, Traber MG. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res. 1993;34:343-358.
46. Sato K, Niki E, Shimasaki H. Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch Biochem Biophys. 1990;279:402-405.
47. Yoshida Y, Tsuchiya J, Niki E. Interaction of α-tocopherol with copper and its effect on lipid peroxidation. Biochim Biophys Acta. 1994;1200:85-92.
48. Lynch SM, Frei B. Reduction of copper, but not iron, by human low density lipoprotein (LDL): implication for metal ion-dependent oxidative modification of LDL. J Biol Chem. 1995;270:5158-5163.
49. Tribble DL, van den Berg JJM, Motchnik PA, Ames BN, Lewis DM, Chait A, Krauss RM. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content. Proc Natl Acad Sci USA. 1994;91:1183-1187.
50. Bowry VW, Mohr D, Cleary J, Stocker R. Prevention of tocopherol-mediated peroxidation of ubiquinol-10-free human low density lipoprotein. J Biol Chem. 1995;270:5756-5763.
51. Witting PK, Bowry VW, Stocker R. Inverse deuterium kinetic isotope effect for peroxidation in human low-density lipoprotein (LDL): a simple test for tocopherol-mediated peroxidation of LDL lipids. FEBS Lett. 1995;375:45-49.
52. Gushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parharni F, Gerrity R, Schwartz CJ, Fogelman AM. Minimally modified low density lipoprotein induces monocyte chemotactic protein (MCP-1) in human endothelial and smooth muscle cells. Proc Natl Acad Sci USA. 1990;87:5134-5138.
53. Hanaki Y, Sugiyama S, Ozawa T, Ohno M. Ratio of low-density lipoprotein cholesterol to ubiquinone as a coronary risk factor. N Engl J Med. 1991;325:814-815.
54. Jialal I, Grundy SM. Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation. Circulation. 1993;88:2780-2786.